首页> 外文OA文献 >Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19

【2h】

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19

机译：羟基氯喹，FaviPiravir以及Lopinavir和Ritonavir的组合治疗新冠状病毒感染Covid-19的“第一波”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
B. K. Romanov;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus [J] . Costanzo Michele, De Giglio Maria Anna Rachele, Roviello Giovanni Nicola Current medicinal chemistry . 2020,第27期

机译：SARS-COV-2：基于Lopinavir / Ritonavir，Darunavir / Umifenovir，羟基氯喹，Remdesivir，FaviPiravir和其他治疗新冠状病毒的抗病毒治疗的报告
2. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum [J] . Habler Katharina, Bruegel Mathias, Teupser Daniel, Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis . 2021,第1期

机译：通过在人血清中的二维同位素稀释LC-MS / MS方法同时定量七种重新灌注的Covid-19药物Remdesivir（Plus代谢GS-441524），氯喹，羟基喹啉，洛诺维尔，蓖麻养，FaviPiravir和氮杂霉素
3. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial [J] . Justin T. Denholm, Joshua Davis, David Paterson, Trials . 2020,第1期

机译：澳大利亚Covid-19试验（ASCOT）评估住院治疗的SARS-COV-2感染（Covid-19）的临床结果与Lopinavir / Ritonavir和/或羟氯喹与护理标准进行治疗：研究方案的结构化概述对于随机对照试验
4. 2019 Novel Coronavirus Disease (Covid-19): Toward a Novel Design for Disinfection Robot to Combat Coronavirus (Covid-19) Using IoT Based Technology [C] . M. N. Mohammed, Nurul Aslamiah Hazairin, Arif Sameh Arif, IEEE Control and System Graduate Research Colloquium . 2021

机译：2019年新型冠状病毒病（Covid-19）：朝着使用基于机器的技术的消毒机器人的新设计，用于打击冠状病毒（Covid-19）
5. Optical 2-D Scanning System for Laser - Generated Shockwave Treatment of Wound Infections. [D] . Patel, Shahzad Neville. 2013

机译：光学二维扫描系统，用于激光产生的冲击波治疗伤口感染。
6. A Randomized Double-Blind Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin Lopinavir/Ritonavir-Doxycycline and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections [O] . Purwati, Budiono, Brian Eka Rachman, 2021

机译：随机双盲多中心临床研究比较Lopinavir / Ritonavir-azithromycinLopinavir / Ritonavir-doxycin-羟基氯喹的药物组合的疗效和安全性用于诊断患有轻度至中度Covid-19感染的患者
7. The comparison of lopinavir/ritonavir combination and favipiravir in COVID-19 treatment [O] . 2021

机译：Lopinavir / Ritonavir组合和FaviPiravir在Covid-19治疗中的比较

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19

著录项

引文网络

相似文献

相关主题

期刊订阅